{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T22:20:40Z","timestamp":1793053240582,"version":"4.5.0"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2019,6,18]],"date-time":"2019-06-18T00:00:00Z","timestamp":1560816000000},"content-version":"vor","delay-in-days":96,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Union Seventh Framework Programme","award":["FP7\/2012-2017"],"award-info":[{"award-number":["FP7\/2012-2017"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and Aims<\/jats:title>\n                    <jats:p>Faecal biomarkers are used as indicators of disease activity in inflammatory bowel diseases [IBD], which include Crohn\u2019s disease [CD] and ulcerative colitis [UC]. Micro-RNAs [miRNAs] are small non-coding RNAs detectable in extracellular fluids and can be used as clinical biomarkers. The aim of this study was to determine if faecal miRNA composition is altered in IBD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>More than 800 different human faecal miRNAs were measured in stool samples from control individuals and patients with active CD by using NanoString technology. Selected miRNAs were quantified by qRT-PCR in faeces, serum and intestinal tissue of controls [n = 23] and patients with inactive or active CD [n = 22, n = 22] or UC [n = 11, n = 24] as well as patients with Clostridium difficile infection [CDI, n = 8].<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In total, 150 miRNAs were significantly detected in faeces from controls and patients, and multivariate analyses showed that CD patients with high disease activities had a distinct miRNA profile and that miR-223 and miR-1246 were distinct from other faecal miRNAs. In a larger cohort, active UC patients displayed significantly higher levels of miR-223 and miR-1246 than controls while patients with CDI had higher levels of faecal miR-1246 but not miR-223. No differences were noted in serum samples.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>To our knowledge, this is the first comprehensive screen of faecal miRNAs performed in IBD. Further investigation will aim to confirm these findings in a larger cohort and to understand the biological function and cellular sources of faecal miRNAs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ecco-jcc\/jjz120","type":"journal-article","created":{"date-parts":[[2019,6,14]],"date-time":"2019-06-14T08:31:29Z","timestamp":1560501089000},"page":"110-117","source":"Crossref","is-referenced-by-count":48,"title":["Faecal Micro-RNAs in Inflammatory Bowel Diseases"],"prefix":"10.1093","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5618-0579","authenticated-orcid":false,"given":"Julien","family":"Verdier","sequence":"first","affiliation":[{"name":"Department of Internal Medicine III, University Hospital RWTH Aachen, Aachen, Germany"},{"name":"INSERM, Sorbonne Universit\u00e9s, UPMC Univ Paris, AIM-Institute of Myology, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene Raphaela","family":"Breunig","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine III, University Hospital RWTH Aachen, Aachen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarete Clara","family":"Ohse","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine III, University Hospital RWTH Aachen, Aachen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Roubrocks","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine III, University Hospital RWTH Aachen, Aachen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Kleinfeld","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine III, University Hospital RWTH Aachen, Aachen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanchari","family":"Roy","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine III, University Hospital RWTH Aachen, Aachen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konrad","family":"Streetz","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine III, University Hospital RWTH Aachen, Aachen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Trautwein","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine III, University Hospital RWTH Aachen, Aachen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Roderburg","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine III, University Hospital RWTH Aachen, Aachen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gernot","family":"Sellge","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine III, University Hospital RWTH Aachen, Aachen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,3,14]]},"reference":[{"key":"2019122411074539900_CIT0001","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.crohns.2009.12.003","article-title":"The second European evidence-based Consensus on the diagnosis and management of Crohn\u2019s disease: definitions and diagnosis","volume":"4","author":"Van Assche","year":"2010","journal-title":"J Crohns Colitis"},{"key":"2019122411074539900_CIT0002","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/ibd.21534","article-title":"Interobserver and intermodality agreement for detection of small bowel Crohn\u2019s disease with MR enterography and CT enterography","volume":"17","author":"Jensen","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"2019122411074539900_CIT0003","first-page":"21","article-title":"Fecal calprotectin in inflammatory bowel disease","volume":"9","author":"Walsham","year":"2016","journal-title":"Clin Exp Gastroenterol"},{"key":"2019122411074539900_CIT0004","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1053\/j.gastro.2016.10.005","article-title":"Advances in use of endoscopy, radiology, and biomarkers to monitor inflammatory bowel diseases","volume":"152","author":"Panes","year":"2017","journal-title":"Gastroenterology"},{"key":"2019122411074539900_CIT0005","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1002\/ibd.22917","article-title":"Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease","volume":"18","author":"D\u2019Haens","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"2019122411074539900_CIT0006","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/ajg.2015.120","article-title":"C-reactive protein, fecal calprotectin, and stool lactoferrin for detection of endoscopic activity in symptomatic inflammatory bowel disease patients: a systematic review and meta-analysis","volume":"110","author":"Mosli","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"2019122411074539900_CIT0007","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1097\/MIB.0000000000000836","article-title":"Emerging biomarkers for the diagnosis and monitoring of inflammatory bowel diseases","volume":"22","author":"Soubi\u00e8res","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"2019122411074539900_CIT0008","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nri.2016.40","article-title":"MicroRNAs as regulatory elements in immune system logic","volume":"16","author":"Mehta","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"2019122411074539900_CIT0009","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1053\/j.gastro.2010.07.040","article-title":"MicroRNAs control intestinal epithelial differentiation, architecture, and barrier function","volume":"139","author":"McKenna","year":"2010","journal-title":"Gastroenterology"},{"key":"2019122411074539900_CIT0010","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/ni.1994","article-title":"Epithelial microRNAs regulate gut mucosal immunity via epithelium-T cell crosstalk","volume":"12","author":"Biton","year":"2011","journal-title":"Nat Immunol"},{"key":"2019122411074539900_CIT0011","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1136\/gutjnl-2012-304213","article-title":"miR-141 regulates colonic leukocytic trafficking by targeting CXCL12\u03b2 during murine colitis and human Crohn\u2019s disease","volume":"63","author":"Huang","year":"2014","journal-title":"Gut"},{"key":"2019122411074539900_CIT0012","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1136\/gutjnl-2015-309389","article-title":"miR-301a promotes intestinal mucosal inflammation through induction of IL-17A and TNF-\u03b1 in IBD","volume":"65","author":"He","year":"2016","journal-title":"Gut"},{"key":"2019122411074539900_CIT0013","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1007\/s10620-017-4567-1","article-title":"Role of MiRNAs in inflammatory bowel disease","volume":"62","author":"Cao","year":"2017","journal-title":"Dig Dis Sci"},{"key":"2019122411074539900_CIT0014","doi-asserted-by":"crossref","first-page":"10513","DOI":"10.1073\/pnas.0804549105","article-title":"Circulating microRNAs as stable blood-based markers for cancer detection","volume":"105","author":"Mitchell","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019122411074539900_CIT0015","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/MOG.0000000000000284","article-title":"MicroRNAs: how many in inflammatory bowel disease?","volume":"32","author":"Schaefer","year":"2016","journal-title":"Curr Opin Gastroenterol"},{"key":"2019122411074539900_CIT0016","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1093\/ibd\/izy046","article-title":"Circulating and fecal microRNAs as biomarkers for inflammatory bowel diseases","volume":"24","author":"Sch\u00f6nauen","year":"2018","journal-title":"Inflamm Bowel Dis"},{"key":"2019122411074539900_CIT0017","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1053\/j.gastro.2013.10.021","article-title":"Crohn\u2019s disease-associated adherent invasive Escherichia coli modulate levels of microRNAs in intestinal epithelial cells to reduce autophagy","volume":"146","author":"Nguyen","year":"2014","journal-title":"Gastroenterology"},{"key":"2019122411074539900_CIT0018","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1111\/jgh.12523","article-title":"Serum microRNA levels in patients with Crohn\u2019s disease during induction therapy by infliximab","volume":"29","author":"Fujioka","year":"2014","journal-title":"J Gastroenterol Hepatol"},{"key":"2019122411074539900_CIT0019","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/ibd.21450","article-title":"Peripheral blood microRNAs distinguish active ulcerative colitis and Crohn\u2019s disease","volume":"17","author":"Wu","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"2019122411074539900_CIT0020","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/cei.12104","article-title":"Identification of serum and tissue micro-RNA expression profiles in different stages of inflammatory bowel disease","volume":"173","author":"Iborra","year":"2013","journal-title":"Clin Exp Immunol"},{"key":"2019122411074539900_CIT0021","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1097\/MIB.0000000000000883","article-title":"Identification of circulating microRNA signatures in Crohn\u2019s disease using the Nanostring nCounter technology","volume":"22","author":"Oikonomopoulos","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"2019122411074539900_CIT0022","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1053\/j.gastro.2008.07.068","article-title":"MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2 alpha","volume":"135","author":"Wu","year":"2008","journal-title":"Gastroenterology"},{"key":"2019122411074539900_CIT0023","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1097\/MIB.0000000000001086","article-title":"Expression and localization of miR-21 and miR-126 in mucosal tissue from patients with inflammatory bowel disease","volume":"23","author":"Thorlacius-Ussing","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"2019122411074539900_CIT0024","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1111\/jgh.13778","article-title":"Alterations in microRNA expression profiles in inflamed and non-inflamed ascending colon mucosae of patients with active Crohn\u2019s disease","volume":"32","author":"Wu","year":"2017","journal-title":"J Gastroenterol Hepatol"},{"key":"2019122411074539900_CIT0025","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.crohns.2014.02.012","article-title":"Rectal microRNAs are perturbed in pediatric inflammatory bowel disease of the colon","volume":"8","author":"Zahm","year":"2014","journal-title":"J Crohns Colitis"},{"key":"2019122411074539900_CIT0026","first-page":"281","article-title":"Diagnostic microRNA markers for screening sporadic human colon cancer and active ulcerative colitis in stool and tissue","volume":"6","author":"Ahmed","year":"2009","journal-title":"Cancer Genomics Proteomics"},{"key":"2019122411074539900_CIT0027","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1158\/1055-9965.EPI-10-0027","article-title":"Fecal MicroRNAs as novel biomarkers for colon cancer screening","volume":"19","author":"Link","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2019122411074539900_CIT0028","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrgastro.2011.59","article-title":"Treatment of refractory and recurrent Clostridium difficile infection","volume":"8","author":"Surawicz","year":"2011","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2019122411074539900_CIT0029","first-page":"93","article-title":"Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle","volume":"10","author":"Ahmed","year":"2013","journal-title":"Cancer Genomics Proteomics"},{"key":"2019122411074539900_CIT0030","first-page":"Unit25B.10","article-title":"Digital multiplexed gene expression analysis using the NanoString nCounter system","volume":"Chapter 25","author":"Kulkarni","year":"2011","journal-title":"Curr Protoc Mol Biol"},{"key":"2019122411074539900_CIT0031","first-page":"9","article-title":"PAST: paleontological statistics software package for education and data analysis","volume":"4","author":"Hammer","year":"2001","journal-title":"Palaeontol Electronica"},{"key":"2019122411074539900_CIT0032","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nbt1385","article-title":"Direct multiplexed measurement of gene expression with color-coded probe pairs","volume":"26","author":"Geiss","year":"2008","journal-title":"Nat Biotechnol"},{"key":"2019122411074539900_CIT0033","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/nature06607","article-title":"Regulation of progenitor cell proliferation and granulocyte function by microRNA-223","volume":"451","author":"Johnnidis","year":"2008","journal-title":"Nature"},{"key":"2019122411074539900_CIT0034","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.cell.2007.04.040","article-title":"A mammalian microRNA expression atlas based on small RNA library sequencing","volume":"129","author":"Landgraf","year":"2007","journal-title":"Cell"},{"key":"2019122411074539900_CIT0035","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3892\/or.2014.3193","article-title":"Global fecal microRNA profiling in the identification of biomarkers for colorectal cancer screening among Asians","volume":"32","author":"Phua","year":"2014","journal-title":"Oncol Rep"},{"key":"2019122411074539900_CIT0036","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.chom.2015.12.005","article-title":"The host shapes the gut microbiota via fecal microRNA","volume":"19","author":"Liu","year":"2016","journal-title":"Cell Host Microbe"},{"key":"2019122411074539900_CIT0037","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1373\/clinchem.2014.221341","article-title":"Circulating microRNA biomarker studies: pitfalls and potential solutions","volume":"61","author":"Witwer","year":"2015","journal-title":"Clin Chem"},{"key":"2019122411074539900_CIT0038","doi-asserted-by":"crossref","first-page":"e2703","DOI":"10.1097\/MD.0000000000002703","article-title":"Circulating MicroRNA223 is a new biomarker for inflammatory bowel disease","volume":"95","author":"Wang","year":"2016","journal-title":"Medicine"},{"key":"2019122411074539900_CIT0039","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1053\/j.gastro.2015.05.057","article-title":"MicroRNA214 is associated with progression of ulcerative colitis, and inhibition reduces development of colitis and colitis-associated cancer in mice","volume":"149","author":"Polytarchou","year":"2015","journal-title":"Gastroenterology"},{"key":"2019122411074539900_CIT0040","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1097\/MIB.0000000000000285","article-title":"Overexpression of miR-595 and miR-1246 in the sera of patients with active forms of inflammatory bowel disease","volume":"21","author":"Krissansen","year":"2015","journal-title":"Inflamm Bowel Dis"}],"container-title":["Journal of Crohn's and Colitis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ecco-jcc\/advance-article-pdf\/doi\/10.1093\/ecco-jcc\/jjz120\/29222347\/jjz120.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/14\/1\/110\/31613525\/jjz120.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/14\/1\/110\/31613525\/jjz120.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,24]],"date-time":"2019-12-24T11:08:18Z","timestamp":1577185698000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article\/14\/1\/110\/5519805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,14]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,3,14]]},"published-print":{"date-parts":[[2020,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ecco-jcc\/jjz120","relation":{},"ISSN":["1873-9946","1876-4479"],"issn-type":[{"value":"1873-9946","type":"print"},{"value":"1876-4479","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,1]]},"published":{"date-parts":[[2019,3,14]]}}}